Tatva Chintan Pharma Chem Limited.
Founded- 1996, 24 years old.
Headquarters- Vadodara, Gujrat.
Key people- Subhash Patel, Mahner Desai, Chintan Shah.
Revenue- 3,062.92 Cr ( March 2021).
Number of employees- 100 plus
Tatva Chintan Pharma Chem Ltd is the leading and only commercial chemical manufacturer. The company was incorporated in 1996, its own second-largest position globally. Its manufacturer is Structure directing Agents (SDAs), Pharmaceutical, Phases transfer catalysts (PTC), and Agrochemicals.
Tatva Chintan Pharma was incorporated in 1996 and commenced the manufacturing of pharmaceutical chemicals.
1996- The company was incorporated on 12 June 1996.
2004- They received licenses from manufacturers for the sale of certain drugs from the food and drugs control Administration.
2007- In 2007, The company expanded the manufacturing installed capacity of the Ankleshwar plant.
2011- Tatva Chintan Pharma Chem started commercial manufacturing of (SDAs) Structure directing agents.
2013- The company FY 2013 turnover reached Rs 500 million rupees.
2015- Tatva Chintan Pharma Chem Ltd, FY 2015 attained a turnover of Rs 1 billion and the same year its incorporation of Tatva Chintan USA Inc. wholly owned subsidiary of their company.
2017- Another manufacturing facility set up by Tatva Chintan Chem Pharma at Dahej, Gujrat
2018- In 2018, the company established their fully equipped R&D Facility in Vadodara, Gujarat.
2019- The company incorporated Tatva Chintan Europe BV, a wholly-owned subsidiary.
2020- In 2020, they converted the Ankleshwar manufacturing facility to a Zero Liquid effluent discharge facility and in this year Company achieved total revenue of Rs 2 billion.
As of Dec 31, 2020, Tatva Chintan Chem Pharma total of 138 products are manufactured and these products are divided into different categories like Structure directing Agent, phase transfer catalyst, electrolyte salt for capacitor batteries, pharmaceutical and Agrochemicals intermediate and other specialty chemicals.
SDAs- Structure Directing Agents are quaternary salt that is used in the function of particular channels and pores duri6 synthesis of zeolites. Zeolites have varied applications including catalysts and adsorbents.
PTC (Phase Transfer Catalyst) is used in the pharmaceutical industry in synthesis, R&D, Drug formulation, laboratory application. It’s widely used in green chemistry.
Electrolyte salt for capacitor batteries has been used in the manufacturing of supercapacitor batteries, which are used in automobile batteries and other batteries.
Pharmaceutical and Agrochemicals: The product manufactured by companies under this category is used in the manufacturing of various pharmaceutical and Agrochemicals products such as intermediate, disinfectant and Catalyst and solvents. The company also manufactures specialty chemicals under this category that are used in dyes and pigment, personal care, flavour and fragrances sectors.
The company currently operates through two manufacturing facilities situated at Dahej and Ankleshwar in Gujarat, India. Both are strategically located very close to the Hazira port. The company’s annual installed manufacturing capacity is 280 KL and It has 13 assembly lines as of March 31, 2020.
Tatva Chintan Pharma Chem manufacturing facilities are equipped with various modern machinery and equipment, including reactors, assembly lines, ANFDs, Centrifugal and RCVD.
- The company received an Appreciation Certificate from the office of the Chief Commission of central excise, customs and Services tax, Vadodara zone.
- They accorded the status of a two-star export house from the directorate general of the foreign trade ministry of commerce and industry-government of India.
- The R&D facility is recognized by the department of scientific and industrial research, the government of India for the purpose of availing of custom duty exemption.
- ISO 9001:2015 Certification for a manufacturing facility at Ankleshwar.
- ISO 140001:2015 and BS OHSAS 18001:2007 Certification for a manufacturing facility at Ankleshwar.
- ISO 14001:2015 and ISO 45001:2018 certification for a manufacturing facility at Ankleshwar.
- ISO 9001:2015 Certification for manufacturing facilities at Ankleshwar and Dahej.
The company plans to raise Rs 500 Cr, offers fresh issue shares worth Rs 225 Cr and an offer for sale of Rs 275 Cr by promotors including Ajay Kumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Shekhar Rasiklal Somani. The price band of the share has been fixed at Rs 1073 to Rs 1083 per equity share. The IPO opens on July 16 and closes on July 20, 2021. Tatva Chintan Chem Pharma shares traded at a 60% premium at Gray market as the IPO opened. Tatva Chintan Pharma Chem’s Rs 500-crore IPO will finalise the basis of allotment on 26 July 2021. Its IPO has 180.36 times subscription, becoming the second-most subscribed IPO of the calendar year 2021. That resulted in a price of Rs 1,703-1,773 per share, a premium of 57-63 % over a higher issue price of Rs 1,083.
Tatva Chintan pharma chem limited listed at Rs 2111.85 on BSE against the issue price of Rs 1083 at a premium of 95 %, stock meeting analysts expectations and grey market premium. The stock of Tatva Chintan extended rally after a debut of around 130 % to hit a day high of Rs 2486.30 on the BSE.
Chief Financial Officer